MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
VTVT vTv Therapeutics
- 14.9600
- +0.4400+3.03%
Close Dec 20 16:00 ET
39.08MMarket Cap-3.42P/E (TTM)
15.1000High14.8200Low5.18KVolume14.8244Open14.5200Pre Close77.06KTurnover0.49%Turnover RatioLossP/E (Static)2.61MShares30.990052wk High2.60P/B15.90MFloat Cap7.380052wk Low--Dividend TTM1.06MShs Float560.0000Historical High--Div YieldTTM1.93%Amplitude7.3800Historical Low14.8680Avg Price1Lot Size
vTv Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -32.77%-6.42M | -9.11%-6.73M | -41.99%-7.34M | -19.09%-19.08M | 57.65%-2.91M | 45.24%-4.83M | -973.51%-6.17M | -405.97%-5.17M | 17.02%-16.02M | -7.22%-6.88M |
| Net income from continuing operations | 31.62%-5.84M | 11.12%-6.41M | -4.24%-6.02M | -3.56%-25.97M | 27.08%-4.44M | -56.18%-8.54M | -76.26%-7.21M | 38.73%-5.77M | -41.41%-25.07M | 35.78%-6.09M |
| Operating gains losses | 52.49%-162K | 36.30%-193K | 55.88%371K | -284.25%-3.64M | -345.38%-3.23M | -205.25%-341K | -471.70%-303K | 148.37%238K | 41.21%-946K | 27.35%-725K |
| Depreciation and amortization | 0.00%22K | 0.00%23K | 0.00%22K | -2.17%90K | 0.00%23K | -8.33%22K | 4.55%23K | -4.35%22K | 3.37%92K | 4.55%23K |
| Other non cash items | ---- | ---- | ---- | 163.20%213K | --0 | --0 | --0 | --213K | ---337K | ---146K |
| Change In working capital | -2,589.58%-1.29M | -180.08%-1.01M | -201.74%-1.93M | -18.40%4.39M | 256.83%1.29M | 98.63%-48K | -72.27%1.26M | -63.27%1.9M | 15,285.71%5.39M | -122.27%-820K |
| -Change in receivables | --64K | --675K | -608.09%-879K | 161.21%71K | 12.07%-102K | --0 | --0 | --173K | -214.85%-116K | -113.32%-116K |
| -Change in prepaid assets | -41.79%-777K | -48.66%268K | -31.55%473K | 458.06%1.44M | 161.94%778K | 3.52%-548K | -24.24%522K | -5.60%691K | 51.97%-403K | -166.10%-1.26M |
| -Change in payables and accrued expense | -213.00%-565K | -362.87%-1.94M | -246.41%-1.51M | 442.17%2.93M | 17.47%659K | 116.93%500K | 125.50%738K | -76.70%1.03M | -146.83%-856K | -83.21%561K |
| -Change in other current assets | --30K | --30K | --28K | --105K | --105K | --0 | --0 | --0 | --0 | ---- |
| -Change in other current liabilities | ---43K | ---42K | ---40K | ---154K | ---154K | --0 | --0 | --0 | --0 | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 772.64%6.76M | 0.00%-9K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -32.77%-6.42M | -9.11%-6.73M | -41.99%-7.34M | -19.09%-19.08M | 57.65%-2.91M | 45.24%-4.83M | -973.51%-6.17M | -405.97%-5.17M | 17.02%-16.02M | -7.22%-6.88M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 21,071.43%4.4M | -21K | 0 | |||||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---21K | --0 |
| Net business purchase and sale | ---- | ---- | ---- | --4.4M | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | 21,071.43%4.4M | ---- | ---- | ---- | ---- | ---21K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 420.72%2.46M | 0 | 324.73%50.14M | -18.69%12M | -107.69%-282K | -92.50%473K | 0 | 4,711.72%11.81M | -45.31%14.75M | 1,278.57%3.67M |
| Net issuance payments of debt | --0 | --0 | -101.62%-191K | -3.13%-33K | -3,597.30%-12.31M | -15.08%473K | --0 | 4,711.72%11.81M | -118.60%-32K | 12.37%-333K |
| Net common stock issuance | --2.46M | --0 | --50.34M | -18.64%12.03M | 23.44%12.03M | --0 | --0 | --0 | -44.74%14.79M | 1,408.67%9.75M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---5.75M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 420.72%2.46M | --0 | 324.73%50.14M | -18.69%12M | -107.69%-282K | -92.50%473K | --0 | 4,711.72%11.81M | -45.31%14.75M | 1,278.57%3.67M |
| Net cash flow | ||||||||||
| Beginning cash position | 261.35%45.53M | 178.46%52.26M | -22.10%9.45M | -9.61%12.13M | -46.29%8.24M | -29.47%12.6M | 54.61%18.77M | -9.61%12.13M | 133.43%13.42M | -21.60%15.34M |
| Current changes in cash | 9.31%-3.96M | -9.11%-6.73M | 544.71%42.81M | -107.91%-2.68M | 137.60%1.21M | -72.78%-4.36M | -207.72%-6.17M | 619.97%6.64M | -116.81%-1.29M | 47.76%-3.21M |
| End cash Position | 404.62%41.57M | 261.35%45.53M | 178.46%52.26M | -22.10%9.45M | -22.10%9.45M | -46.29%8.24M | -29.47%12.6M | 54.61%18.77M | -9.61%12.13M | -9.61%12.13M |
| Free cash flow | -32.77%-6.42M | -9.11%-6.73M | -41.99%-7.34M | -18.94%-19.08M | 57.65%-2.91M | 45.24%-4.83M | -1,000.29%-6.17M | -405.97%-5.17M | 16.91%-16.04M | -7.22%-6.88M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.